Global Adult Immune Cell Storage Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Adult Immune Cell Storage Market Research Report 2024
Immune cell storage refers to the use of biotechnology to extract a certain number of healthy immune cells from the human body. After testing and identification, they are stored in deep-temperature liquid nitrogen tanks at -150°C to -196°C to maintain the activity of immune cells for a long time, is a functional kind of business. Immune cell banking utilizes healthy cells to treat diseased cells, such as cancer cells. Immune cells can specifically scan the body for mutations that may be linked to cancer. When they do find these mutations, the cells work to eliminate them. Immune cells are an important line of defense for the human body to resist the invasion of foreign substances and eliminate aging, mutated, and cancerous cells. Human immunity reaches its peak at the age of 20. With age, environmental deterioration, bad living habits and other factors, the number of immune cells and Quality continues to decline and incidence rates gradually increase. When the body is in good condition, immune cells are stored in advance and health assets are proactively managed.
According to MRAResearch’s new survey, global Adult Immune Cell Storage market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
Immunotherapy is an emerging treatment method that uses a patient's own immune cells to fight life-threatening diseases such as cancer. This is important because the average person's chance of developing cancer in their lifetime is about 33 percent and increases with age. As of 2023, there are currently at least 6 FDA-approved cellular immunotherapies for cancer treatment, with more being investigated every day.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Adult Immune Cell Storage market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
HealthBanks
Aeterna Health
Cell Vault
Redermis
Innovita Research
STEMCELL
Enhance Biomedical
Immunaeon
Miracell
Maharaj Institute
FullHope Biomedical
Ivy Life Sciences
Vectorite Biomedical
Zhong Ji 1 International Medical
OrganaBio
VCANBIO
Beike Biotechnology
H&B
Shanghai Cell Therapy Group
BGI CELL
ICELL
SALIAI
S-Evans Biosciences
Zhengda Stem Cell Bank
Liaoning Huize Health Biotech
Supercell Biotechnology
Guangxi Academy of Sciences Cell Bank
Bailing Stem Cell
Retain Biotech
Segment by Type
NK Cells
T cells
B Cells
Adjuvant Treatment for Cancer
Anti Aging Treatment
Regulate Sub-Health
Prevention
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Adult Immune Cell Storage report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Adult Immune Cell Storage market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
Immunotherapy is an emerging treatment method that uses a patient's own immune cells to fight life-threatening diseases such as cancer. This is important because the average person's chance of developing cancer in their lifetime is about 33 percent and increases with age. As of 2023, there are currently at least 6 FDA-approved cellular immunotherapies for cancer treatment, with more being investigated every day.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Adult Immune Cell Storage market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
HealthBanks
Aeterna Health
Cell Vault
Redermis
Innovita Research
STEMCELL
Enhance Biomedical
Immunaeon
Miracell
Maharaj Institute
FullHope Biomedical
Ivy Life Sciences
Vectorite Biomedical
Zhong Ji 1 International Medical
OrganaBio
VCANBIO
Beike Biotechnology
H&B
Shanghai Cell Therapy Group
BGI CELL
ICELL
SALIAI
S-Evans Biosciences
Zhengda Stem Cell Bank
Liaoning Huize Health Biotech
Supercell Biotechnology
Guangxi Academy of Sciences Cell Bank
Bailing Stem Cell
Retain Biotech
Segment by Type
NK Cells
T cells
B Cells
Segment by Application
Adjuvant Treatment for Cancer
Anti Aging Treatment
Regulate Sub-Health
Prevention
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Adult Immune Cell Storage report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source